propranolol has been researched along with Amblyopia in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Amblyopia: A nonspecific term referring to impaired vision. Major subcategories include stimulus deprivation-induced amblyopia and toxic amblyopia. Stimulus deprivation-induced amblyopia is a developmental disorder of the visual cortex. A discrepancy between visual information received by the visual cortex from each eye results in abnormal cortical development. STRABISMUS and REFRACTIVE ERRORS may cause this condition. Toxic amblyopia is a disorder of the OPTIC NERVE which is associated with ALCOHOLISM, tobacco SMOKING, and other toxins and as an adverse effect of the use of some medications.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management." | 7.80 | Monitoring propranolol treatment in periocular infantile haemangioma. ( Burne, R; Taylor, R, 2014) |
| "To develop a tool for assessing amblyopic risk and monitoring the treatment effect of propranolol in periocular haemangioma management." | 3.80 | Monitoring propranolol treatment in periocular infantile haemangioma. ( Burne, R; Taylor, R, 2014) |
| "Propranolol has recently been introduced as a novel pharmacologic treatment for infantile haemangiomas, after Leaute-Labreze and colleagues observed that two patients being treated for cardiac indications had rapid regression of their haemangiomas." | 1.39 | Capillary haemangioma successfully treated with oral beta-blocker in Dar es Salaam, Tanzania: a case report. ( Blaikie, A; Cloke, A; Lim, LT, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ojha, HR | 1 |
| Verma, N | 1 |
| Burne, R | 1 |
| Taylor, R | 1 |
| Cloke, A | 1 |
| Lim, LT | 1 |
| Blaikie, A | 1 |
3 other studies available for propranolol and Amblyopia
| Article | Year |
|---|---|
Early management of capillary haemangioma to prevent stimulus-deprivation amblyopia.
Topics: Amblyopia; Child; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Propranolol; Timo | 2022 |
Monitoring propranolol treatment in periocular infantile haemangioma.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Amblyopia; Child; Child, Preschool; D | 2014 |
Capillary haemangioma successfully treated with oral beta-blocker in Dar es Salaam, Tanzania: a case report.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amblyopia; Facial Neoplasms; Female; Hemangioma, | 2013 |